Evidence Library
Filter by drug, type, year, and open access.
Showing 1–5 of 5 results
- Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: systematic review and network meta-analysis — The Lancet (2022)• Drug: eszopicloneDOIPMID
- FDA boxed warning for serious injuries caused by complex sleep behaviors with certain prescription insomnia medicines — FDA Drug Safety Communication (2019)• Drug: eszopicloneOpen access
- Eszopiclone for insomnia (Cochrane Review) — Cochrane Database of Systematic Reviews (2018)• Drug: eszopicloneOpen accessDOIPMIDPMCID
- Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline — Journal of Clinical Sleep Medicine (2017)• Drug: eszopicloneOpen accessDOIPMIDPMCID
- Sustained efficacy of eszopiclone over 6 months of nightly treatment: randomized, double-blind, placebo-controlled study in adults with chronic insomnia — Sleep (2003)• Drug: eszopicloneDOIPMID